Related Experiment Videos
A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator
K C Chou1, K D Watenpaugh, R L Heinrikson
1Computer-Aided Drug Discovery, Pharmacia & Upjohn, Kalamazoo, Michigan 49007-4940, USA.
Abstract:
Tau protein kinase II (TPKII) is a heterodimer comprising a catalytic cyclin-dependent kinase subunit (Cdk5) and a regulatory protein called neuronal Cdk5 activator (Nck5a). TPKII is somewhat reminiscent, therefore, of the Cdk2-cyclin complex important in cell cycle regulation. In fact, although the amino acid sequence of Nck5a has little similarity to those of cyclins, recent experimental results obtained by site-directed mutagenesis studies have indicated that its activation domain, Nck5a*, may adopt a conformation of the cyclin-fold structure. Based on this structural inference, a 3-dimensional model of the Cdk5-Nck5a*-ATP complex was derived from the X-ray structure of Cdk2-cyclinA-ATP complex. The computed structure for TPKII is fully compatible with experimental data derived from studies of the Cdk5-Nck5a system, and also predicts which amino acid residues might be involved in formation of the Cdk5-Nck5a* interface and ATP binding pocket in TPKII. The computational structure also shows the interactive region of Nck5a* and the T-loop of Cdk5, a critical region in TPKII which functions as a gate-control-lever of the catalytic cleft. Furthermore, a physical mechanism is put forth to explain why the activation of TPKII is not dependent upon phosphorylation of the Cdk5 subunit, a puzzle long-standing in this area. These findings provide a model with which to consider design of compounds which might serve as inhibitors of TPKII.
Insights
A 3D model of Tau protein kinase II (TPKII) reveals its structure and activation mechanism. This computational model, based on experimental data, aids in designing potential TPKII inhibitors.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Tau protein kinase II (TPKII) is a crucial enzyme composed of Cdk5 and Nck5a.
- Its activation mechanism has been a long-standing puzzle, particularly regarding Cdk5 phosphorylation.
- Nck5a's activation domain may adopt a cyclin-fold structure, similar to Cdk2-cyclin complexes.
Purpose of the Study:
- To derive a 3D structural model of the Cdk5-Nck5a*-ATP complex.
- To elucidate the structural basis of TPKII activation and identify key interacting residues.
- To propose a mechanism for TPKII activation independent of Cdk5 phosphorylation.
Main Methods:
- Computational modeling based on the X-ray structure of Cdk2-cyclinA-ATP.
- Site-directed mutagenesis data integration.
- Analysis of protein-protein interfaces and ATP binding pockets.
Main Results:
- A 3D model of the Cdk5-Nck5a*-ATP complex compatible with experimental data was generated.
- Key residues at the Cdk5-Nck5a* interface and ATP binding site were predicted.
- The model highlights the interaction between Nck5a* and Cdk5's T-loop, crucial for catalytic activity.
Conclusions:
- The study provides a structural framework for understanding TPKII function.
- A mechanism explaining TPKII activation independent of Cdk5 phosphorylation is proposed.
- The findings offer a basis for designing novel TPKII inhibitors.